Wednesday, April 23, 2008

Accutane Verdict of $10.6 Million

A New Jersey jury hit Roche with a $10.6 million verdict in favor of a Utah woman who claimed that the acne medication Accutane caused her inflammatory bowel disease.  The jury, finding that Roche provided inadequate labeling, awarded plaintiff Kamie Kendall $78,500 for past medical expenses plus $10.5 million in unspecified compensation.  Here's a brief story in the Star-LedgerPharmalot notes that this verdict is Roche's third Accutane trial loss (another in New Jersey last June, and one in Florida last fall), and that the company faces about 400 Accutane suits.


Pharmaceuticals - Misc. | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference Accutane Verdict of $10.6 Million :

» Acne Topical Antibiotics from Acne Topical Antibiotics
Find out more about the antibiotics used for acne cont [Read More]

Tracked on Sep 30, 2008 2:25:36 AM


I'm glad to hear that she'll be compensated but I hope that Roche doesn't ever go broke. I took antibiotics and used topical medications for years without much success. A 6 month course of accutane was what finally "cured" me. It's been years since I took my last pill and my face is still 99.9% clear. The only side effect that I still feel from the accutane is that my eyes are a bit dry and I can't wear my contact lenses at night like I could before taking it.

Posted by: Paul | Jul 1, 2008 5:20:26 PM

Post a comment